Find a Doctor

Find a Researcher

Darius Anthony Rastegar, M.D.

Medical Director, Addiction Medicine Unit, Johns Hopkins Bayview Medical Center
Associate Professor of Medicine

Male

Languages: English, Farsi, Persian

Expertise

General Internal Medicine, Hepatitis C (HCV), HIV/AIDS, Substance Use Disorders ...read more

Request an Appointment

Insurance Information

Request Appointment

International Patients

+1-410-502-7683

Request Appointment

Locations

Johns Hopkins Bayview Medical Center

Appointment Phone: 410-550-2999

5200 Eastern Avenue
Mason Lord Building, East Tower, 2nd Floor
Baltimore, MD 21224 map

Phone: 410-550-2999 | Fax: 410-367-2442

Background

Dr. Darius Rastegar is an associate professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include primary care internal medicine, addiction medicine, and HIV/AIDS.

He serves as medical director of the Inpatient Addiction Medicine Unit at Johns Hopkins Bayview Medical Center and the program director for the Johns Hopkins Addiction Medicine Fellowship.

Dr. Rastegar earned his M.D. from the University of Pennsylvania. He completed his internal medicine residency at Johns Hopkins Bayview Medical Center.

Titles

Medical Director, Addiction Medicine Unit, Johns Hopkins Bayview Medical Center
Program Director, Addiction Medicine Fellowship
Associate Professor of Medicine

Departments / Divisions

Medicine - Division of Addiction Medicine
Medicine - Addiction Medicine

Centers & Institutes

Education

Degrees

MD; University of Pennsylvania School of Medicine (1991)

Residencies

Internal Medicine; Johns Hopkins Bayview Medical Center (1994)

Board Certifications

American Board of Internal Medicine (Internal Medicine) (1994)
American Board of Preventive Medicine (Addiction Medicine) (2018)

Research & Publications

Selected Publications

Buresh M, Stern R, Rastegar D. Treatment of opioid use disorder in primary care. BMJ. 2021 May 19;373:n784. doi: 10.1136/bmj.n784. PMID: 34011512

Rastegar DA, Applewhite D, Alvanzo AAH, Welsh C, Niessen T, Chen ES. Development and implementation of an alcohol withdrawal protocol using a 5-item scale, the Brief Alcohol Withdrawal Scale (BAWS). Subst Abus. 2017 Oct-Dec;38(4):394-400. doi: 10.1080/08897077.2017.1354119. Epub 2017 Jul 12. PMID: 28699845

Kawasaki SS, Jacapraro JS, Rastegar DA. Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification. J Subst Abuse Treat. 2012 Oct;43(3):331-4. doi: 10.1016/j.jsat.2011.12.011. Epub 2012 Jan 28. PMID: 22285834

Soeffing JM, Martin LD, Fingerhood MI, Jasinski DR, Rastegar DA. Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year. J Subst Abuse Treat. 2009 Dec;37(4):426-30. doi: 10.1016/j.jsat.2009.05.003. Epub 2009 Jun 23. PMID: 19553061

Pytell JD, Rastegar DA. Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic. J Subst Abuse Treat. 2021 Jan;120:108155. doi: 10.1016/j.jsat.2020.108155. Epub 2020 Oct 5. PMID: 33298297; PMCID: PMC7534596

Activities & Honors

Memberships

American Society of Addiction Medicine (Fellow)
American College of Physicians (Fellow)

Videos & Media

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

Is this you? Edit Profile